Page 1 Date 11 November 2020 Re: Management Discussion & Analysis for the 9-months period Ended 30 September 2020 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN PUBLIC
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Page 1 of 3 No. ACC6411/003 November 11, 2021 Subject: Clarification of the operating results quarter 3/2021 of the year ended September 30, 2021 Attention : Director and Managing Director, The Stock
Page 1 of 3 No. ACC6502/005 February 28, 2022 Subject: Clarification of the operating results Year 2021 of the year ended December 31, 2021 Attention : Director and Managing Director, The Stock
recent development in this area is the SEC Board’s approval of amendments to the Stock Exchange of Thailand (SET) regulations to improve the screening process for companies applying for SET listing and to
According to a referral from the Stock Exchange of Thailand (SET) and the SEC’s further investigation, it was revealed that during 13 December 2022 – 30 January 2023, STARK disclosed information
strengthening capacities of the organization to cope with change and achieve the SEC Mission.”Ms. Ruenvadee Suwanmongkol, SEC Secretary-General, said: “In laying out the SEC Strategic Plan 2021-2023, we took into
capital market.SEC has initiated a plan to push new channels towards an easier accessibility for investors to the capital market, and to be able to swiftly change the type of services or called “the ease
corporate governance. Another key change to the assessment is the introduction of an independent validation in addition to the existing peer-review process. The enhancements are being introduced to strengthen
: Management explanation and analysis for the yearly ending 31 December 2018 Attention: The President of, The Stock Exchange of Thailand ZIGA Innovation Public Company Limited ( “ the Company” ) would like to